Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators

Heart Rhythm

Volumn 6, Issue 4, 2009, Pages 468-473

  Cygankiewicz, Iwona ^a   Gillespie, John ^b   Zareba, Wojciech ^a   Brown, Mary W ^a   Goldenberg, Ilan ^a   Klein, Helmut ^a   McNitt, Scott ^a   Polonsky, Slava ^a   Andrews, Mark ^a   Dwyer, Edward M ^c   Hall, W Jackson ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Implantable cardioverter defibrillator; Mortality; Risk stratification

Indexed keywords

UREA;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CLINICAL STUDY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEFIBRILLATOR; ELECTROCARDIOGRAM; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; REGISTER; RISK ASSESSMENT; SINUS RHYTHM; SURVIVAL RATE; SURVIVAL TIME; SURVIVOR; UREA NITROGEN BLOOD LEVEL;

BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 62749091650     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.12.023     Document Type: Article

References (23)

1. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 335 (1996) 1933-1940
2. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
3. Moss A.J., Zareba W., Hall W.J., et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
4. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
5. Hohnloser S.H., Kuck K.H., Dorian P., et al., DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
6. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
7. European Heart Rhythm Association, European Society of Cardiology, Ector H., and Vardas P. Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association. Eur Heart J 9 Suppl 9 (2007) 144-149
8. Borleffs C.J.W., Wilde A.A.M., Wever E., et al. Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation?. Neth Heart J 15 (2007) 129-132
9. Goldenberg I., Vyas A.K., Hall W.J., et al., MADIT-II Investigators. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51 (2008) 288-296
10. Hauser R.G. The growing mismatch between patients longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol 45 (2005) 2022-2025
11. Agarwal S.K., Singla I., Hreybe H., et al. Predictors of mortality amongst recipients of implantable cardioverter defibrillators for secondary prevention of cardiac arrest. Indian Pacing Electrophysiol J 7 (2007) 218-224
12. Thibodeau J.B., Pillarisetti J., Khumri T.M., et al. Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation. Am J Cardiol 101 (2008) 861-864
13. Lee D.S., Tu J.V., Austin P.C., et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 49 (2007) 2408-2415
14. Parkash R., Stevenson W.G., Epstein L.M., et al. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 151 (2006) 397-403
15. Zwanziger J., Hall W.J., Dick A.W., et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 2310-2318
16. Goldberger I., Moss A.J., Hall W.J., et al. Multicenter Automatic Defibrillator Implantation Trial. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 113 (2006) 2810-2817
17. Bigger Jr. J.T., Whang W., Rottman J.N., et al. Mechanisms of death in the CABG Patch Trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 99 (1999) 1416-1421
18. Eckart R.E., Gula L.J., Reynolds M.R., et al. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 17 (2006) 940-943
19. Wase A., Basit A., Nazir R., et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 11 (2004) 199-204
20. Bailey J.J., Berson A.S., Handelsman H., et al. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 38 (2001) 1902-1911
21. Exner D.V., Kavanagh K.M., Slawnych M.P., et al., REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50 (2007) 2275-2284
22. Klingenheben T., and Hohnloser S.H. Usefulness of risk stratification for future cardiac events in infarct survivors with severely depressed versus near-normal left ventricular function: results from a prospective long-term follow-up study. Ann Noninvasive Electrocardiol 8 (2003) 68-74
23. Olona M., Candell-Riera J., Permanyer-Miralda G., et al. Strategies for prognostic assessment of uncomplicated first myocardial infarction: 5-year follow-up study. J Am Coll Cardiol 25 (1995) 815-822